COVID-19: Up to 82% critically ill patients had low Vitamin C values

There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epid...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomasa-Irriguible, Teresa Maria, Bielsa-Berrocal, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269403/
https://www.ncbi.nlm.nih.gov/pubmed/34243781
http://dx.doi.org/10.1186/s12937-021-00727-z
_version_ 1783720571972878336
author Tomasa-Irriguible, Teresa Maria
Bielsa-Berrocal, Lara
author_facet Tomasa-Irriguible, Teresa Maria
Bielsa-Berrocal, Lara
author_sort Tomasa-Irriguible, Teresa Maria
collection PubMed
description There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.
format Online
Article
Text
id pubmed-8269403
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82694032021-07-09 COVID-19: Up to 82% critically ill patients had low Vitamin C values Tomasa-Irriguible, Teresa Maria Bielsa-Berrocal, Lara Nutr J Short Report There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19. BioMed Central 2021-07-09 /pmc/articles/PMC8269403/ /pubmed/34243781 http://dx.doi.org/10.1186/s12937-021-00727-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
Tomasa-Irriguible, Teresa Maria
Bielsa-Berrocal, Lara
COVID-19: Up to 82% critically ill patients had low Vitamin C values
title COVID-19: Up to 82% critically ill patients had low Vitamin C values
title_full COVID-19: Up to 82% critically ill patients had low Vitamin C values
title_fullStr COVID-19: Up to 82% critically ill patients had low Vitamin C values
title_full_unstemmed COVID-19: Up to 82% critically ill patients had low Vitamin C values
title_short COVID-19: Up to 82% critically ill patients had low Vitamin C values
title_sort covid-19: up to 82% critically ill patients had low vitamin c values
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269403/
https://www.ncbi.nlm.nih.gov/pubmed/34243781
http://dx.doi.org/10.1186/s12937-021-00727-z
work_keys_str_mv AT tomasairriguibleteresamaria covid19upto82criticallyillpatientshadlowvitamincvalues
AT bielsaberrocallara covid19upto82criticallyillpatientshadlowvitamincvalues

Ejemplares similares